Separate names with a comma.
Hello everyone, I'm being offered a VS2 role in the pharma side of the Bayer business and was wondering how senior is this role within the...
What's the outlook for DBU in PC in terms of pipeline, job security etc? And base salary for someone with 3 years field experience?
Hey yall, I know this question comes up alot but pharma or med-device. I just recieved a Pharma offer but also am in the 2 round of interviews...
In an exclusive interview with the AlphaStreet, ImmunoGen Inc (NASDAQ: IMGN) executive chief Mark Enyedy spoke about the company's product...
Hello, Dear forum members, While I am finishing my thesis, I am in lack of answers for my 5 min study and particularly from shareholders &...
Merck surpassed analysts’ expectations for revenue and earnings in the third quarter of 2019, sending the shares climbing 2.5% in premarket hours...
Eli Lilly surpassed earnings expectations for the third quarter of 2019 but revenues came in shy of estimates. Total revenue grew 3%...
Abbott Laboratories’ third quarter 2019 earnings came in line with the market’s projections, while sales missed the expectations. The pharma...
Earnings of Johnson & Johnson increased and topped the Street view in Q3 helped by a 2% growth in sales. Encouraged by the positive outcome, the...
Bristol-Myers-Squibb announced that Amgen will acquire Celgene’s Otezla business for $13.4 billion in a cash transaction. Bristol-Myers now...
Here's another good show by Alexion Pharma...! June-quarter financial results surpassed the consensus estimates of Wall Street analysts, powered...
Biogen reported second-quarter earnings that surpassed Wall Street expectations. The company reported adjusted earnings of $9.15 per share, way...
Novartis on Thursday surprised Wall Street by reporting a year-over-year increase in net earnings in Q2, helped by higher sales and a one-time...
I am hearing that this company might be the next big thing. Anyone?
JNJ kicked off pharma earnings as it posted its first-quarter 2019 earnings on Tuesday, April 16, before the opening bell. Reported revenue for...
What do startups and modern pharma companies have in common? There are two factors mentioned in article Embracing the Start-up Mindset in Pharma :...
JNJ saw sales inch 1% up to $20.4 billion in the fourth quarter of 2018. Operational sales results rose 3.3%. Domestic sales increased 1.5%, while...
I expect that Amarin will bounce back from the recent sell-off. Most of the doctors who participated in the AHA event has said that they will...
What's the reason for Celgene going down even after beating the estimates and lifting 2018 outlook? Any thoughts?...
After announcing positive results for the treatment of cystic fibrosis, Proteostasis Therapeutics stock skyrocketed more than 400% and reached the...
